The largest database of trusted experimental protocols

Quantikine human comp immunoassay

Manufactured by R&D Systems
Sourced in United Kingdom

The Quantikine® Human COMP Immunoassay is a quantitative sandwich enzyme immunoassay designed to measure human cartilage oligomeric matrix protein (COMP) levels in cell culture supernates, serum, and plasma. It utilizes a monoclonal antibody specific for COMP coated on a microplate.

Automatically generated - may contain errors

5 protocols using quantikine human comp immunoassay

1

Regulation of COMP Release from OA Cartilage

Check if the same lab product or an alternative is used in the 5 most similar protocols
Release of COMP from OA cartilage was measured in the supernatants of SF cultures over cartilage explants.13 OA joint cartilages from four patients were provided by the Rheumatology Service at Complejo Hospitalario Universitario A Coruña (CHUAC, A Coruña, Spain). Fixed diameter (6 mm) sections were collected from adjacent areas to the injured cartilage. Samples were frozen at −80°C and stored until testing. One explant per well was attached to a 96‐well plate. HD‐ or OA‐SF were added drop‐wise on top of the cartilage surface (2 × 104 SF per explant). After 3 hours of incubation, wells were filled with DMEM in the presence or absence of 10 µM PD98059 or 200 ng/mL DKK1 for 1 hour, followed by treatment with 10 ng/mL IL‐1β or 10 nM 45 kDa Fn‐fs. Cultures were continued for 7 days, and treatments were renewed every two days. Culture supernatants were collected for detection of COMP using a Quantikine® Human COMP Immunoassay (R&D Systems).
+ Open protocol
+ Expand
2

Analyzing GAG and COMP Release from OA Cartilage

Check if the same lab product or an alternative is used in the 5 most similar protocols
Release of glycosaminoglycans (GAGs) and COMP degradation products from cartilage tissue was measured in culture medium from wells containing SF cultured over cartilage explants. Osteoarthritis human cartilages were obtained from three patients undergoing total hip arthroplasty in Hospital del Mar (Barcelona, Spain). Fixed diameter (6 mm) and height (2 mm) sections were collected from cartilage areas without macroscopically signs of OA. The samples were frozen at −80°C and stored until testing. One explant per well was attached to a 24 well plate. Healthy donors‐ or OA‐SF were added drop‐wise on top of the cartilage surface (2 × 104 SF/explant). After 3 hrs of incubation at 37°C, wells were filled with 1 ml DMEM 10% FBS, with the treatments described, and cultures were continued for 14 days. Culture supernatants were collected to detect the release of GAGs and COMP degradation products, using a Blyscan Sulfated Glycosaminoglycan Assay (Biocolor Ltd, County Antrim, Ireland, UK), and a Quantikine® Human COMP Immunoassay (R&D Systems, Abingdon, OX, UK), respectively. Cartilage explants were placed in OCT and frozen in liquid nitrogen. Sections were prepared using a cryostat, placed on slides and stained with Alcian blue and Callejas's tricromic.
+ Open protocol
+ Expand
3

Quantifying BMP-4 and COMP in Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMP-4 ELISA was performed using a RayBiotech human BMP-4 ELISA kit. Following the manufacturer’s protocol, 100 µl of cell culture supernatant samples were loaded into the wells of a 96-well plate, along with recombinant BMP-4 protein standards, incubated overnight at 4°C, and developed using the provided horseradish peroxidase (HRP)–streptavidin system. The standard curve was plotted using SigmaPlot software. A best-fit line was drawn through the standards data points, and the unknown concentrations of the samples were calculated. COMP ELISA was performed using an R&D Systems Quantikine human COMP immunoassay. Following the manufacturer’s protocol, 50 µl of cell culture supernatants was loaded onto a 96-well plate with 100 µl of assay diluent, incubated overnight at 4°C with recombinant COMP protein standards, and developed using HRP–streptavidin after incubation with a Ready-to-Use COMP conjugate. Standards were plotted on a log graph, and a best-fit line was determined to allow calculation of the concentration in the experimental samples.
+ Open protocol
+ Expand
4

Serum COMP Enzyme Immunoassay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All blood samples (3 ml) were drawn from an antecubital vein using a 20-gauge shielded I.V. catheter (BD Vialon Insyte Autoguard, Becton Dickinson & Co., Franklin Lakes, NJ, USA) that was placed during the 30-minute rest period. After insertion, the catheter was flushed with 1 ml of isotonic saline (0.9% NaCl) every 15 min to prevent clotting. Prior to collecting blood, a 1-ml waste sample was drawn. Blood samples were placed in EDTA vacutainers (BD Vacutainer K2 EDTA, Decton Dickinson & Co., Franklin Lakes, NJ, USA), centrifuged for 15 min at 3000×g, and then stored at -20 °C. Serum COMP concentration was determined using manufacturer guidelines from a commercially available enzyme-linked immunosorbent assay (Quantikine Human COMP Immunoassay, R&D Systems Inc., Minneapolis, MN, USA). Blood samples were analyzed in triplicate. Intra-and inter-assay coefficients of variation were 1.5% and 18.4% for a 165 ± 37 ng ml -1 sample. We minimized inter-assay variation by comparing serum COMP concentration for each subject on the same plate.
+ Open protocol
+ Expand
5

Cartilage Explant Co-culture Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Release of GAG and COMP from cartilage was measured in culture supernatants from wells containing co-cultures of SF over cartilage explants. 20 OA human cartilages were obtained from three patients undergoing total hip arthroplasty from Hospital del Mar (Barcelona, Spain). Fixed diameter (6 mm) and height (2 mm) sections were collected from cartilage areas without macroscopic signs of OA. Samples were frozen at À80 C and stored until testing. One explant per well was attached to a 24-well plate. HD-or OA-SF were added drop-wise on top of the cartilage surface (2 Â 10 4 SF per explant). After 3 hours of incubation, wells were filled with DMEM in the absence or presence of 10 ng/ mL IL-1b or 10 nmol/L Fn-fs 45 kDa, and cultures were continued for 14 days. Culture supernatants were collected for detection of GAG and COMP, using a Blyscan Sulfated Glycosaminoglycan Assay (Biocolor Ltd County Antrim, Ireland, UK), and a Quantikine Human COMP Immunoassay (R&D Systems, Abingdon, OX, UK), respectively. Frozen sections were prepared using a cryostat and stained with Alcian blue and Callejas's tricromic. Sections were observed using an Olympus BX51 microscope with DP72 camera model (objective 20Â).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!